Clinical and Basic Researches Related to ZhenQi Buxue Oral Liquid in Treating Menstrual Disorders

Summary

This study is a national multicenter prospective, randomized, controlled trial, which evaluates Zhenqi Buxue Oral Liquid，Progesterone Capsules and the addition of Zhenqi Buxue Oral Liquid to Progesterone Capsules in the treatment of menstrual disorders in adults women. One third of participanta will receive Zhenqi Buxue Oral Liquid, one third of participanta will receive Progesterone Capsules, and the another third will receive Zhenqi Buxue Oral Liquid and Progesterone Capsules in combination.

Conditions

• Menstrual Disorders

Interventions

DRUG

ZhenQi BuXue KouFuYe

Zhenqi Buxue Oral Liquid consists of sheep placenta, pearl, red ginseng, wolfberry, astragalus, angelica, coix seed, ginger and jujube. The excipients are protein sugar and sodium benzoate. Nourishes qi and blood. It is suitable for dizziness, pale complexion, fatigue, lack of energy and lazy words caused by insufficient qi and blood.

DRUG

Progesterone Capsules

The main ingredient of Progesterone Capsules is abbsolutely progesterone,a kind of hormone,which is the main method of western medicine for the treatment of menstrual disorders

Sponsors & Collaborators

• West China Second University Hospital

  collaborator OTHER

• Chongqing Medical University No.1 Affiliated Hospital

  collaborator UNKNOWN

• The Second Hospital of Hebei Medical University

  collaborator OTHER

• Second Affiliated Hospital of Nanchang University

  collaborator OTHER

• Zhongda Hospital

  collaborator OTHER

• Hubei Maternal and Child Health Hospital

  collaborator UNKNOWN

• Liuzhou Maternity and Child Healthcare Hospital

  collaborator OTHER

• Zhejiang University Medical College Affiliated Hangzhou First People's Hospital

  collaborator UNKNOWN

• Guangzhou Women and Children's Medical Center

  collaborator OTHER

• Peking Union Medical College Hospital

  lead OTHER

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Model

PARALLEL

Eligibility

Min Age

25 Years

Max Age

40 Years

Sex

FEMALE

Healthy Volunteers

No

Timeline & Regulatory

Start

2022-03-15

Primary Completion

2022-12-30

Completion

2023-06-30

Countries

• China

Study Locations